June Lee - Jan 6, 2022 Form 4 Insider Report for CinCor Pharma, Inc. (CINC)

Role
Director
Signature
/s/ Cathy Rude, Attorney-in-Fact
Stock symbol
CINC
Transactions as of
Jan 6, 2022
Transactions value $
$0
Form type
4
Date filed
1/10/2022, 03:15 PM
Previous filing
Nov 22, 2021
Next filing
Feb 2, 2022

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction CINC Stock Option (Right to Buy) Award $0 +48K $0.00 48K Jan 6, 2022 Common Stock 48K $16.00 Direct F1
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 This option vests in equal annual installments over a three-year period measured from one year following January 11, 2022, subject to the continued service by the Reporting Person to the Issuer as of the applicable vesting date.